These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27261231)

  • 1. Phytonadione oral liquid.
    Stumpf JL; Ciarkowski SL; Leja N; Jaynes EK
    Am J Health Syst Pharm; 2016 Jun; 73(12):858-61. PubMed ID: 27261231
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of various phytonadione (vitamin K1) administration routes in achieving warfarin reversal.
    Laible B
    S D Med; 2007 Apr; 60(4):158-9. PubMed ID: 17555152
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
    Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
    Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation.
    Poli D; Antonucci E; Lombardi A; Gensini GF; Abbate R; Prisco D
    Haematologica; 2003 Feb; 88(2):237-8. PubMed ID: 12604423
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Intravenous Versus Subcutaneous Phytonadione on Length of Stay for Patients in Need of Urgent Warfarin Reversal.
    Mottice BL; Soric MM; Legros E
    Am J Ther; 2016; 23(2):e345-9. PubMed ID: 25461960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vitamin K1: an option to reduce warfarin's activity.
    Harrell CC; Kline SS
    Ann Pharmacother; 1995 Dec; 29(12):1228-32. PubMed ID: 8672826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing different routes and doses of phytonadione for reversing excessive anticoagulation.
    Whitling AM; Bussey HI; Lyons RM
    Arch Intern Med; 1998 Oct; 158(19):2136-40. PubMed ID: 9801181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged coagulopathy after brodifacoum exposure.
    Underwood EL; Sutton J; Ellis IK; Qualls B; Zamber J; Walker BN
    Am J Health Syst Pharm; 2014 Apr; 71(8):639-42. PubMed ID: 24688037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
    Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
    Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practical aspects of peroral anticoagulant treatment].
    Hansen HH
    Ugeskr Laeger; 2001 Dec; 163(50):7085. PubMed ID: 11794049
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of oral versus intravenous phytonadione in patients with excessive anticoagulation.
    Key N
    Curr Hematol Rep; 2004 Sep; 3(5):315-6. PubMed ID: 15341696
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous vitamin K1 injections: dangerous prophylaxis.
    O'Reilly RA; Kearns P
    Arch Intern Med; 1995 Oct; 155(19):2127-8. PubMed ID: 7575074
    [No Abstract]   [Full Text] [Related]  

  • 15. The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation.
    Tripodi A; Moia M
    J Thromb Haemost; 2012 Oct; 10(10):2207-8. PubMed ID: 22882756
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects.
    van Rein N; Gebuis EP; Lijfering WM; Groeneveld JJ; van der Horst FA; le Cessie S; Rosendaal FR; van der Meer FJ
    J Thromb Haemost; 2014 Dec; 12(12):2017-23. PubMed ID: 25308231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment: oral vitamin K1 to reverse warfarin activity.
    Weathermon RA; Heyscue BE; Garris RE
    Ann Pharmacother; 1996; 30(7-8):886-7. PubMed ID: 8826584
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
    Shields RC; McBane RD; Kuiper JD; Li H; Heit JA
    Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma concentrations of vitamin K1 and acenocoumarol related to international normalized ratios].
    Gougnard T; Charlier C; David JL; Plomteux G
    Acta Clin Belg; 1999; 53 Suppl 1():32-4. PubMed ID: 10216979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency use of intravenous phytonadione (vitamin K1) for treatment of severe bleeding in a child with chronic cholestasis.
    Glatstein M; Idan-Prusak D; Yahav A; Ovental A; Rimon A; Scolnik D
    Am J Ther; 2013; 20(6):e733-5. PubMed ID: 21642829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.